Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 16, 2022

SELL
$1.23 - $3.25 $17,958 - $47,450
-14,600 Closed
0 $0
Q1 2022

May 17, 2022

SELL
$2.0 - $3.28 $1,000 - $1,640
-500 Reduced 3.31%
14,600 $29,000
Q4 2021

Feb 15, 2022

SELL
$3.14 - $5.15 $50,240 - $82,400
-16,000 Reduced 51.45%
15,100 $47,000
Q1 2021

May 18, 2021

SELL
$5.61 - $12.01 $356,235 - $762,635
-63,500 Reduced 67.12%
31,100 $174,000
Q3 2020

Nov 17, 2020

BUY
$8.49 - $19.54 $803,154 - $1.85 Million
94,600 New
94,600 $803,000
Q1 2020

May 15, 2020

SELL
$6.94 - $14.22 $188,768 - $386,784
-27,200 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$7.99 - $37.6 $217,328 - $1.02 Million
27,200 New
27,200 $218,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.24B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.